NCT06057038 2026-03-03A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid TumorsGenmabPhase 1 Active not recruiting42 enrolled
NCT04632108 2025-09-11A 1/2 Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ASKB589 in Patients With Locally Advanced or Metastatic Solid TumorsJiangsu Aosaikang Pharmaceutical Co., Ltd.Phase 1/2 Active not recruiting199 enrolled